The Importance of a Multidisciplinary Team in Building Bladder Cancer Guidelines
Jeffrey Holzbeierlein, M.D., University of Kansas Medical Center, discusses how important it was that a multidisciplinary team came together to create the non-metastatic muscle-invasive bladder cancer guidelines.
Jeffrey Holzbeierlein, M.D., University of Kansas Medical Center, discusses how important it was that a multidisciplinary team came together to create the non-metastatic muscle-invasive bladder cancer guidelines.
A group of professionals from various organizations, such as the American Urologic Association and ASCO, as well as those working in medical and radiation oncology, and a patient advocate from the Bladder Cancer Advocacy Network (BCAN) all came together to form these guidelines, which are the first guidelines made for this disease type.
Including a team of professionals and advocates -- rather than just having a group of urologists make the guidelines -- gives the guidelines more validity and credibility, and helps to educate patients and professionals across the different realms of oncology.
FDA Approves 3 Treatments, Cancer Vaccine Shows Promise
December 20th 2023The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.
Listen
